{"nct_id":"NCT04927247","title":"A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises","status":"TERMINATED","status_verified_date":"2024-11","start_date":"2021-12-09","start_date_type":"ACTUAL","primary_completion_date":"2023-11-24","primary_completion_date_type":"ACTUAL","completion_date":"2023-11-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}